StockNow
Calendar
Log in
U.S. Markets

Eli Lilly (LLY) announces new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound in adults with Psoriasis and Obesity

StockNow breaking-news AI analysis

The October headline announces exploratory TOGETHER-PsO data, but provides no findings. An earlier February release reported positive 36-week topline results; it does not verify the newer announcement's results.

1 stocks
LLYEli Lilly & Co.$1,166.23Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

A US military source told Al-Hadath that "US forces received orders to mobilise last Sunday"; "We have replaced thousands of missiles and sent our forces the ammunition they need"

Geopolitics

"[Yemen] Government forces complete control over Bab al-Mandab after clearing it", Al Hadath reports citing sources

Geopolitics

IRGC Navy political affairs officer says vessels violating restrictions in the Strait of Hormuz are punished every night, via Arabic TV